{
    "nctId": "NCT00555477",
    "briefTitle": "Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure",
    "officialTitle": "Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 69,
    "primaryOutcomeMeasure": "The Number of Women Who Recover Ovarian Function Within 12 Months of Al Monotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\nTo be eligible for this study:\n\n1. You must be at least 18 years of age and not older than 60 years of age\n2. You have breast cancer which was confined to the breast and lymph nodes under the arm, and have no evidence of cancer elsewhere\n3. You must have had surgical removal of your tumor, and if indicated, radiation therapy must have been completed or planned\n4. Your tumor must express estrogen and/or progesterone receptors\n5. You must have had a menstrual period within 6 months before starting chemotherapy for your breast cancer.\n6. You must have been treated with a chemotherapy regimen that includes cyclophosphamide (Cytoxan). Your menstrual periods must have stopped for at least 8 weeks starting during or after chemotherapy.\n\nExclusion Criteria:\n\nYou are not eligible to participate in this study if:\n\n1. Your ovaries have been surgically removed, treated with radiation therapy, or if you are taking medications (Zoladex\u2122 or Lupron\u2122) to block the function of your ovaries.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}